Literature DB >> 31060974

Carbapenem-Resistant Enterobacteriaceae: An update narrative review from Saudi Arabia.

Fawzia Alotaibi1.   

Abstract

Carbapenem-Resistant Enterobacteriaceae (CRE) is a worldwide urgent public health problem. Similar to other countries, Saudi Arabia is facing the challenge of increasingly reported cases of CRE. The aim of this review is to bring and update on the prevalence, epidemiology and microbiological characteristics of CRE reported from Saudi Arabia.
Copyright © 2019 The Author. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Carbapenem-resistant Enterobacteriaceae (CRE); Saudi Arabia

Mesh：

Substances：

Year:  2019        PMID： 31060974     DOI： 10.1016/j.jiph.2019.03.024

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN： 1876-0341            Impact factor:   3.718


  7 in total

1.  Molecular epidemiology and outcome of carbapenem-resistant Enterobacterales in Saudi Arabia.

Authors:  Basem M Alraddadi; Emily L G Heaphy; Yamama Aljishi; Waleed Ahmed; Khalid Eljaaly; Hanan H Al-Turkistani; Abeer N Alshukairi; Mohammed O Qutub; Kholoud Alodini; Roaa Alosaimi; Waseem Hassan; Dalya Attalah; Rakan Alswaiel; Mohammed F Saeedi; Mohammed A Al-Hamzi; Lama K Hefni; Reem S Almaghrabi; Mushira Anani; Abdulhakeem Althaqafi
Journal:  BMC Infect Dis       Date:  2022-06-13       Impact factor: 3.667

2.  Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae.

Authors:  Basem M Alraddadi; Mohammed Saeedi; Mohammed Qutub; Abeer Alshukairi; Ashraf Hassanien; Ghassan Wali
Journal:  BMC Infect Dis       Date:  2019-09-04       Impact factor: 3.090

3.  Pharmacokinetics of meropenem in critically ill patients in Saudi Arabia.

Authors:  Abdullah Alsultan; Shereen A Dasuqi; Fadi Aljamaan; Rasha A Omran; Saeed Ali Syed; Turki AlJaloud; Abdullah AlAhmadi; Saeed Alqahtani; Mohammed A Hamad
Journal:  Saudi Pharm J       Date:  2021-10-08       Impact factor: 4.330

4.  Effects of Zinc Oxide Nanoparticles Synthesized Using Aspergillus niger on Carbapenem-Resistant Klebsiella pneumonia In Vitro and In Vivo.

Authors:  Elsayim Rasha; Manal M Alkhulaifi; Monerah AlOthman; Ibrahim Khalid; Elnagar Doaa; Khatab Alaa; Manal A Awad; Mohnad Abdalla
Journal:  Front Cell Infect Microbiol       Date:  2021-11-16       Impact factor: 5.293

5.  Carbapenem-Resistant Enterobacteriaceae: A Retrospective Review of Presentation, Treatment, and Clinical Outcomes in a Tertiary Care Referral Hospital.

Authors:  Mohammed Al Khamis; Zainab AlMusa; Mai Hashhoush; Narjis Alsaif; Abdul Salam; Manal Atta
Journal:  Cureus       Date:  2022-07-21

6.  Profile of the Gut Microbiome Containing Carbapenem-Resistant Enterobacteriaceae in ICU Patients.

Authors:  Anees A Sindi; Sarah M Alsayed; Ibrahim Abushoshah; Diyaa H Bokhary; Nisreen R Tashkandy
Journal:  Microorganisms       Date:  2022-06-28

7.  Preliminary exploration on the serum biomarkers of bloodstream infection with carbapenem-resistant Klebsiella pneumoniae based on mass spectrometry.

Authors:  Jinfeng Bao; Yating Ma; Mengshan Ding; Chi Wang; Gaofei Du; Yuan Zhou; Ling Guo; Haiquan Kang; Chengbin Wang; Bing Gu
Journal:  J Clin Lab Anal       Date:  2021-07-31       Impact factor: 2.352
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.